Patients using steroids, especially at high-doses, before taking immune checkpoint inhibitors for non–small cell lung cancer ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...

New indication based on results of RATIONALE-309 study demonstrating statistically significant improvement in progression-free survival ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives FDA priority review. Read more here.

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

The NCCN has added taletrectinib to its recommendations for use in all lines of treatments for non–small cell lung cancer ...